Find a lawyerOur capabilitiesYour career
Locations
Our capabilities
News

Select language:

Locations
Our capabilities
News

Select language:

hamburger menu showcase image
Frankfurt am Main

Dr. Sabrina Kulenkamp

Partner
sabrina.kulenkamp@freshfields.com
Frankfurt am Main: +49 69 27 30 80
hero-banner-image

About

Sabrina advises listed and non-listed clients in stock corporation law and capital markets law, including Corporate Governance, and monitors regularly national and cross-border private and public M&A transactions.

She also is also experienced in carve-outs, delistings and squeeze-outs. Companies listed on the DAX and MDAX trust her on the preparation and conduct of their annual general meetings.

Beyond her client work, Sabrina also serves as the firm's HR Partner for Germany & Austria.

She speaks German, English, Spanish and Armenian.

Capabilities

Corporate advisory and governance
Environment, social and governance
Mergers and acquisitions
Life sciences

VCARD

Download

Connect

Email

Select language

German
Additional Information

Sabrina’s Experience includes:

  • DHL Group on the modernisation of its group structure
  • Uber on public takeover of Delivery Hero
  • Novartis on the public takeover of MorphoSys, the delisting purchase offer and the merger squeeze-out
  • Vienna Insurance Group on their public purchase offer for Nürnberger Beteiligungs-AG  
  • Zentiva on public purchase offer for Apontis Pharma
  • BASF on the merger between Wintershall Dea and Harbour Energy
  • BorgWarner on the public takeover of Akasol
  • TE Connectivity on the public takeover of First Sensor and on the conclusion of a domination and profit and loss pooling agreement with Akasol
  • Beisheim on shareholder agreement relating to METRO AG
  • Volkswagen Financial Services on its corporate restructuring and reorganization
  • OSRAM Licht on the competing public takeover offers by Bain Capital/Carlyle and ams, the domination and profit and loss pooling agreement with ams and the delisting
  • London Stock Exchange on the proposed business combination with Deutsche Börse
  • STADA Arzneimittel in the context of the auction process and subsequent public takeover by Bain Capital and Cinven as well as the conclusion of a domination and profit and loss pooling agreement with Bain Capital and Cinven 

“One of the most respected corporate lawyers of the country”
— Handelsblatt
big quote image

Dr. Sabrina Kulenkamp

Partner
sabrina.kulenkamp@freshfields.com

T +49 69 27 30 80

Frankfurt am Main Office

Große Gallusstraße 14

Frankfurt am Main 60315

NAVIGATE TO
About usLocations and officesYour careerOur thinkingOur capabilitiesNews
CONNECT
Find a lawyerAlumniContact us
NEED HELP
Fraud and scamsComplaintsTerms and conditions
LEGAL
AccessibilityCookiesLegal noticesTransparency in supply chains statementResponsible procurementPrivacy

Select language:
Select language:
© 2026 Freshfields. Attorney Advertising: prior results do not guarantee a similar outcome